Crocs, Inc. · Consumer Cyclical
Paid for today, but breaks on a small cut — or only looks over-priced at a 9% discount rate.
At a 17.0% margin the price needs 3.6% a year of revenue growth against a 3.4% 3-year consensus: cushion -1.0pt (+2.0pt at 1pt lower r) against a 1pt correction cut; survival rests on the discount rate or a cut smaller than a flush. Price pays a flat-to-shrinking path with HEYDUDE not recovering.
Would recover if: Fragile breaks down if 3y consensus is cut by more than 0.0pt or margin settles below 17.0%; it upgrades if margin holds at consensus 21.3%. Watch: Investor conferences, early Dec 2026 (dates not in input).. We re-check this against analyst estimates every evening.
10 years, at a 17% margin analysts expect
+3.0%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
10 published targets, set before the drop
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 153% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 22, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
At the price, the stock sits at the 30th percentile of published models, rejecting both the bull case for a HEYDUDE recovery and the bear case for sustained decline, effectively endorsing a flat-to-shrinking revenue trajectory.
Whether HEYDUDE's sales declines have bottomed and can return to growth, which can be partially tested by tracking unit volumes but cannot be fully settled without retail pricing data.
What the price refuses to pay for, and the full reconstruction, on the CROX quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names